Form 8-K - Current report:
SEC Accession No. 0001193125-25-317728
Filing Date
2025-12-12
Accepted
2025-12-12 17:00:28
Documents
10
Period of Report
2025-12-11
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K itrm-20251211.htm   iXBRL 8-K 46085
  Complete submission text file 0001193125-25-317728.txt   150351

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itrm-20251211.xsd EX-101.SCH 24813
12 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20251211_htm.xml XML 4519
Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104
Business Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 251568972
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)